Needham & Company
-
Needham sees over 130% upside in this Biotech stock
-
Needham & Company Starts Immuneering Corporation (IMRX) at Buy; Sees Over 200% Upside
-
Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference
-
Immuneering to Present at the 22nd Annual Needham Virtual Healthcare Conference
-
Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
-
Immuneering Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

